Rep. Gilbert Ray Cisneros Jr. (D-CA) Buys WUXIF Stock

Representative Gilbert Ray Cisneros Jr. made a stock purchase of WuXi AppTec Co., Ltd. (WUXIF) on September 18, 2026. The transaction is valued between $1,001 and $15,000, according to a periodic transaction report filed under the STOCK Act, which he disclosed on October 12, 2026.

Inside Gilbert Ray Cisneros Jr.'s Trade

Cisneros, a Democrat representing California's 31st district, bought shares of WuXi AppTec valued in the range of $1,001 to $15,000. This purchase reflects his continued interest in the healthcare sector, particularly in a company that provides research and manufacturing services for drug development.

Other Institutional Activity in WuXi AppTec

Legato Capital Management LLC holds 18,040 shares of WuXi AppTec, valued at about $487,080. They did not change their position recently, maintaining their stake in the company.

WuXi AppTec Co., Ltd. Stock Holds Steady

The stock of WuXi AppTec recently traded around $27.00, which is above its 50-day moving average by 4.6%. However, it is still below its 52-week high of $29.10 by about 7.2%. This positioning suggests a stable interest in the stock, especially considering its solid performance in the healthcare sector.

Recent Earnings

WuXi AppTec reported trailing twelve-month revenue of approximately $51.5 billion and an earnings per share (EPS) of $1.05. The company has a net margin of 42.3% and a return on equity (ROE) of 28.4%. Their next earnings report is set for October 26, 2026.

Dividend

WuXi AppTec pays an annual dividend of $0.15 per share, which translates to a dividend yield of 0.56%. The company has a dividend payout ratio of 22.0%, indicating a commitment to returning value to shareholders.

Insider Buying and Selling at WuXi AppTec Co., Ltd.

Several insiders have sold shares of WuXi AppTec recently. Chief Executive Officer Ge Li sold 154,867 shares at an average price of $13.51 on December 16, 2025, totaling about $2,091,587. Co-CEO Minzhang Chen sold 101,830 shares at an average price of $15.15 on January 16, 2026, amounting to approximately $1,542,235. He also sold 161,408 shares at $15.44 on January 19, 2026, for around $2,492,478. Ge Li sold another 150,000 shares at $25.69 on August 13, 2026, totaling about $3,853,395.

About WuXi AppTec

WuXi AppTec Co., Ltd. is a healthcare company based in Shanghai, China. It provides research and manufacturing services to assist in the development of small molecule drugs. The company operates through various segments, including WuXi Chemistry and WuXi Testing, serving clients worldwide.

Bottom Line

Investors should keep an eye on WuXi AppTec's upcoming earnings report scheduled for October 26, 2026. With ongoing insider selling and a new purchase from Cisneros, the company's activities and stock performance will be closely monitored.